Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed

The Food and Drug Administration is offering a funding opportunity to support expanded education, outreach, and public awareness initiatives focused on the use and potential health risks of skin lightening products, such as hydroquinone, through its Office of Minority Health and Health Equity. The goal is to develop innovative, community-based strategies that enhance the scientific foundation for public health messaging and increase awareness among affected populations. This initiative seeks to strengthen understanding of the dangers associated with these products and promote safer consumer behaviors through culturally competent and accessible programs. Applicants are expected to propose activities that engage stakeholders and communities directly, with an emphasis on evidence-based approaches that can be scaled or replicated. The funding is not intended for clinical trials and is aligned with the FDA’s broader mission to protect public health by addressing disparities in health information and outcomes. The opportunity is open to eligible organizations with no specific set-aside requirements and is administered under a U01 grant mechanism. All proposals must be submitted through Grants.gov, and inquiries can be directed to Terrin Brown at the provided contact information.